Previous research has shown that HOXC10 is overexpressed in numerous tumors [21–23], where it promotes tumor cell proliferation through the activation of signaling pathways such as the MAPK and ERBB3/PI3K/AKT axes [29–31]. The gene discussed is ERBB3; the disease is neoplasm.